Effects of corporate social responsibility on pharmaceutical multinational enterprises performance: Research and development and business efficiency perspectives

This study employs an integrated two‐stage network data envelopment analysis, multiplicative efficiency aggregation in a second‐order cone programming approach, to assess efficiency scores of 41 pharmaceutical multinational enterprises (PMNEs). We also suggest a strategy for efficiently forecasting...

Full description

Saved in:
Bibliographic Details
Published in:Managerial and decision economics 2022-12, Vol.43 (8), p.3419-3434
Main Authors: Kao, Fang Chen, Le, Minh‐Hieu
Format: Article
Language:English
Subjects:
Companies
Data envelopment analysis
Governance
Multinational corporations
R&D
Research & development
Social responsibility
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study employs an integrated two‐stage network data envelopment analysis, multiplicative efficiency aggregation in a second‐order cone programming approach, to assess efficiency scores of 41 pharmaceutical multinational enterprises (PMNEs). We also suggest a strategy for efficiently forecasting each PMNE's future efficiency score using a trend analysis technique. In particular, this study investigates how the three dimensions of corporate social responsibility (CSR) affect R&D efficiency and business efficiency. Results indicate that the governance pillar (social pillar) has a positive (negative) effect on the business efficiency of PMNEs. The findings give PMNE executives additional references to consider when deciding on CSR practices.
ISSN:0143-6570
1099-1468
DOI:10.1002/mde.3605